Stress may be the reason people with obesity are more likely to get other metabolic diseases, such as type 2 diabetes, ...

Key Takeaways Amgen refutes in a press release that its trial obesity drug, MariTide, may cause bone loss density. Amgen's ...

The long-term consequences of this metabolic dysfunction are extensive. (Image Credits: Pixabay) Diabetes risk and obesity: ...

While Viking may look like a lucrative opportunity, the stock has already run up considerably this year based on news and speculation. Novo Nordisk dominates diabetes treatment and obesity care ...